首页> 外国专利> Transient Receptor Potential antagonists of vanilloides 1 (TRPV1) useful for treating Pain and inflammation

Transient Receptor Potential antagonists of vanilloides 1 (TRPV1) useful for treating Pain and inflammation

机译:Vanilloides 1(TRPV1)的瞬时受体潜在拮抗剂可用于治疗疼痛和炎症

摘要

Item 1: a compound whose characteristics are to respond to formula (1) or a dissolved salt, to produce a salt, or a mixture, from an acceptable pharmaceutical product, wherein R1 represents a group of pharmacists,(b)(C) o (d)Rx, in each case, represents an alternative to any double ring replaceable position selected from a set of bitumen, halogen, halide, Wu, O (bitumen),O (halogen)NH2, n (H) (person)And n (TAR) 2; R is hydrogen or methyl; R2 and R3 are equal or different, and each is an independent hydrogen, C1-5 tar or halogen tar; or R2 and R3, together with the carbon atoms attached to them, form a single cyclic chemical cyclohexane with 3 to 6 carbon atoms, which can be replaced by 1, 2 or 3 carbon atoms. Selected from the bitumen and halogen groups; R4 in each case represents an alternative to any double ring replaceable position selected from the bitumen, halogen, halide or (bitumen) group,O (halogen)[7 - [7 - [7 - (trifluoro-7] - 1 - (3] - 1 - [7 - [7] - 7 - [7] - 7 - [7 1. Dihydro-2h-chromium-4-il] urea; 1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1 - (L) - (L) - (n) - - isoquinol-5-ilurea; N - (6-chloro-7-methyl-3, 4-dihydro-2h-chromium-4-1) - n '- 1h-indazol-4-ilurea;3-3-3-3-fluoro-3-3-3-3-6) (1); N - (4-3-3-fluoro-3-3-6 (b) urea; N - (6-methyl-3, 4-dihydro-2h-chromium-4-il) - n '(3-methylisoquinine-5-il); [7] - [i-ethan] - [I-7] - [i-ethan] - [i-ethan] - [7] - [i-ethan] - [3. Trifluoroid-3, 4-dihydro-2h-chromium-4-il;N-1H-indazol-4-yl-N '- [8- (trifluoromethyl) -3,4-dihydro-2H-chromen-4-yl] urea; (-) - N-1H-indazol-4-yl-N '- [7- (trifluoromethyl) -3,4-dihydro-2H-chromen-4-yl] urea; (+) - N-1H-indazol-4-yl-N '- [7- (trifluoromethyl) -3,4-dihydro-2H-chromen-4-yl] urea; N-1H-indazol-4-yl-N '- (8-piperidin-1-yl-3,4-dihydro-2H-chromen-4-yl) urea; N- (8-tert-butyl-3,4-dihydro-2H-chromen-4-yl) -N'-1H-indazol-4-ylurea; N- [8-Chloro-7- (trifluoromethyl) -3,4-dihydro-2H-chromen-4-yl] -N'-1H-indazol-4-ylurea; (+) - N- (8-tert-butyl-3,4-dihydro-2H-chromen-4-yl) -N'-1H-indazol-4-ylurea; (-) - N- (8-tert-butyl-3,4-dihydro-2H-chromen-4-yl) -N'-1H-indazol-4-ylurea; N-1H-indazol-4-yl-N '- [8- (trifluoromethoxy) -3,4-dihydro-2H-chromen-4-yl] urea;N- [8-fluoro-7- (trifluoromethyl) -3,4-dihydro-2H-chromen-4-yl] -N'-1H-indazol-4-ylurea; N-1H-indazol-4-yl-N '- [7- (trifluoromethoxy) -3,4-dihydro-2H-chromen-4-yl] urea; N- (6-fluoro-2-methyl-3,4-dihydro-2H-chromen-4-yl) -N'-1H-indazol-4-ylurea; N-1H-indazol-4-yl-N '- (7-methoxy-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl) urea; N-1H-indazol-4-yl-N '- (7-methoxy-2,2,8-trimethyl-3,4-dihydro-2H-chromen-4-yl) urea; N-1H-indazol-4-yl-N '- (2,2,8-trimethyl-3,4-dihydro-2H-chromen-4-yl) urea; N-1H-indazol-4-yl-N '- (7-methoxy-2,2-dimethyl-8-propyl-3,4-dihydro-2H-chromen-4-yl) urea; N- (2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl) -N'-1H-indazol-4-ylurea; N- (7-fluoro-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl) -N'-1H-indazol-4-ylurea;N- (7-fluoro-2,2-diethyl-3,4-dihydro-2H-chromen-4-yl) -N'-1H-indazol-4-ylurea; N- (7,8-difluoro-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl) -N'-1H-indazol-4-ylurea; N- (7- (3,3-dimethylbutyl) -3,4-dihydro-2H-chromen-4-yl) -N'-1H-indazol-4-ylurea; N- (7-tert-butyl-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl) -N'-1H-indazol-4-ylurea; N- (2,2-diethyl-7-fluoro-3,4-dihydro-2H-chromen-4-yl) -N '- (1-methyl-1H-indazol-4-yl) urea; N- (7,8-difluoro-3,4-dihydro-2H-chromen-4-yl) -N'-1H-indazol-4-ylurea; N- (7-fluoro-2,2-dipropyl-3,4-dihydro-2H-chromen-4-yl) -N'-1H-indazol-4-ylurea; N- (2,2-dibutyl-7-fluoro-3,4-dihydro-2H-chromen-4-yl) -N'-1H-indazol-4-ylurea; N- (2-tert-butyl-7-fluoro-3,4-dihydro-2H-chromen-4-yl) -N'-1H-indazol-4-ylurea;7, 6-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1 -- 3, 4-dihydro-2h-chromium-4-il urea; N - [(4R) - 3, 4-dihydro-2h-chromium-4-il] - n '(7-hydroxy-5, 6, 7, (7-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-4-il) urea; 1 - (7-fluorospiro [croman-2, 1 '- ciciochotan] - 4-il) - 3 - (1h-indazol-4-il) urea;(1 - (1) - 1-1 - (1 - (1 -) (1 1. Urea [cr-2, 1L Cyclohexan] - 4-il) - 3 - (1h-indazol-4-il) urea; 1 - (7-tertbutilesepiro [cr-2], - 1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1 '- cyclopentanone] - 4-1) urea; 1 - (7-etoxiespiro [croman-2, 1' - cyclopentanone] - 4-il) - 3 - (1h-indazol-4-il) urea;1]] - 1] - 1 -, 1 - (1 -, 1 - (1 - [(L) 3 - (7-methoxyspiro [cr-2, 1 '- cyclohexane] - 4-il) urea; (+ -) 1 - (3, 4-dihydro-2), - toluene toluene toluene toluene 3 - (benzene toluene toluene toluene toluene toluene - (6) - 1 - (6-methoxy-3,4-dihydro-2,2-dimethyl-2h-1-benzodiazo-4-il) - 3 - (isoquinine-5-il) urokinase;3, 3, 3, 3, 3-methylmethylmethyltoluene-toluene, 3, 3-methyltoluene-an-4-il) - 3 - (1-methylisoquinine-5-il) urea; (+ -) 1 - (6-bromo-3, 4-dihydro-2) Urea; (+ -) 1 - (3,4-dihydro-helix - [2h-1-benzodiazepine-2,1 '- cyclobutan] - 4-il) - 3 - (isoquinolin-5-il) urea;(+) 1- (3,4-dihydro-spiro- [2H-1-benzopyran-2,1'-cyclobutan] -4-yl) -3- (isoquinolin-5-yl) urea; (-) 1- (3,4-dihydro-spiro- [2H-1-benzopyran-2,1'-cyclobutan] -4-yl) -3- (isoquinolin-5-yl) urea; (+ -) 1- (3,4-dihydro-spiro- [2H-1-benzopyran-2,1'-cyclobutan] -4-yl) -3- (8-chloroisoquinolin-5-yl) urea; (+ -) 1- (3,4-Dihydro-spiro- [2H-1-benzopyran-2,1'-cyclobutan] -4-yl) -3- (3-methylisoquinolin-5-yl) urea; (+ -) 1- (3,4-Dihydro-spiro- [2H-1-benzopyran-2,1'-cyclobutan] -4-yl) -3- (1-methylisoquinolin-5-yl) urea; (+ -) 1- (3,4-dihydro-6-methyl-spiro- [2H-1-benzopyran-2,1'-cyclobutan] -4-yl) -3- (isoquinolin-5-yl) urea; (+ -) 1- (3,4-dihydro-7-methyl-spiro- [2H-1-benzopyran-2,1'-cyclobutan] -4-yl) -3- (isoquinolin-5-yl) urea;]],,, [1 - [1 - [3 - [3 - [3 - [3 - [3 - [3 - [3-2h-1-benzopiran-2, 1 '- cyclobutan] - 4-il) - 3 - (isoquinolin-5-il) urea; (+ -) 1 - (3), (1) 1 -------- (1 -------- 1.1-2,1 '- cyclobutan] - 4-il) - 3 - (isoquinolin-5-il) urea;1 - (different from - 1 -) (1 -) (1 -) (different from - 2 h-1-benzopiran-2, 1 '- cyclobutan] - 4-il) - 3 - (3-methylisoquinine-5-il) urea; 1 - (1 -) (1 -) (1 -) (1 -) (1 -) (1 -) (1-1. Dihydro helix - [2h-1-benzodiazo-2, 1 '- cyclohexane] - 4-il) - 3 - (isoquinol-5-il) urea;(1 - (2h-1-benzopiran-2, 1 '- cyclobutan] - 4-il) - 3 - (isoquinolin-5-il) urea; (+ -) 1 - (6-bromo-3), 6] - [6] - [6] - [6] - 1 - [6] - 1-4 - [6 - [6] - 4-4-4-1. Zopiran-2, 1 '- cyclobutan] - 4-il) - 3 - (isoquinolin-5-il) urea;-) (different from - 1 -) (1 -) (1 -) (1 -) (different from from from 5) 1 - (chloro-1 -) (from 3 - [2h-1-benzopiran-2, 1 '- cyclobutan] - 4-il) - 3 - (8-chloroisoquinlin-5-il) urea; (+ -) 1 - (6-fluoro-3)
机译:第1项:其特征是响应式(1)的化合物或溶解的盐,从可接受的药品中制得盐或混合物,其中R1代表一组药剂师,(b)(C)o (d)在每种情况下,Rx代表任何双环可替换位置的替代形式,该位置选自沥青,卤素,卤化物,Wu,O(沥青),O(卤素)NH2,n(H)(人)和n(TAR)2; R为氢或甲基; R2和R3相同或不同,各自为独立的氢,C1-5焦油或卤素焦油; R 2和R 3以及与它们相连的碳原子一起形成具有3至6个碳原子的单个环状化学环己烷,其可以被1、2或3个碳原子取代。选自沥青和卤素基团;在每种情况下,R 4代表从沥青,卤素,卤化物或(沥青)组中选择的任何双环可取代位置的替代物,O(卤素)[7-[7-[7-(三氟-7]-1-(3 ]-1-[7-[7]-7-[7]-7-[7 1.二氢-2h-铬-4-il]尿素; 1-1-1-1-1-1-1-1 -1-1-1-1-1-1-1-1-1-1-1-(L)-(L)-(n)--异喹诺醇5-尿素; N-(6-氯7 -甲基-3,4-二氢-2h-铬-4-1)-n'-1h-吲唑-4-ilurea; 3-3-3-3-氟-3-3-3-3-6)( 1); N-(4-3-3-氟-3-3-6(b)尿素; N-(6-甲基-3,4-二氢-2h-铬-4-il)-n'(3 -甲基异奎宁-5-il); [7]-[i-ethan]-[I-7]-[i-ethan]-[i-ethan]-[7]-[i-ethan]-[3.三氟化合物-3,4-二氢-2h-铬-4-il; N-1H-吲唑-4-基-N'-[8-(三氟甲基)-3,4-二氢-2H-铬-4-基]尿素;(-)-N-1H-吲唑-4-基-N′-[7-(三氟甲基)-3,4-二氢-2H-铬-4-基]尿素;(+)-N-1H-吲唑-4-基-N'-[7-(三氟甲基)-3,4-二氢-2H-铬-4-基]尿素; N-1H-吲唑-4-基-N'-(8-哌啶-1 -yl-3,4-二氢-2H-chromen-4- yl)尿素; N-(8-叔丁基-3,4-二氢-2H-铬-4-基)-N'-1H-吲唑-4-基脲; N- [8-氯-7-(三氟甲基)-3,4-二氢-2H-铬-4-基] -N'-1H-吲唑-4-基脲; (+)-N-(8-叔丁基-3,4-二氢-2H-铬-4-基)-N'-1H-吲唑-4-基脲; (-)-N-(8-叔丁基-3,4-二氢-2H-铬-4-基)-N'-1H-吲唑-4-基脲; N-1H-吲唑-4-基-N′-[8-(三氟甲氧基)-3,4-二氢-2H-铬-4-基]脲; N- [8-氟-7-(三氟甲基)-3 ,4-二氢-2H-铬-4-基] -N′-1H-吲唑-4-基脲; N-1H-吲唑-4-基-N′-[7-(三氟甲氧基)-3,4-二氢-2H-铬-4-基]脲; N-(6-氟-2-甲基-3,4-二氢-2H-铬-4-基)-N'-1H-吲唑-4-基脲; N-1H-吲唑-4-基-N′-(7-甲氧基-2,2-二甲基-3,4-二氢-2H-铬-4-基)脲; N-1H-吲唑-4-基-N′-(7-甲氧基-2,2,8-三甲基-3,4-二氢-2H-铬-4-基)脲; N-1H-吲唑-4-基-N′-(2,2,8-三甲基-3,4-二氢-2H-铬-4-基)脲; N-1H-吲唑-4-基-N′-(7-甲氧基-2,2-二甲基-8-丙基-3,4-二氢-2H-铬-4-基)脲; N-(2,2-二甲基-3,4-二氢-2H-铬-4-基)-N'-1H-吲唑-4-基脲; N-(7-氟-2,2-二甲基-3,4-二氢-2H-铬-4-基)-N'-1H-吲唑-4-基脲; N-(7-氟-2,2- -二乙基-3,4-二氢-2H-铬-4-基)-N′-1H-吲唑-4-基脲; N-(7,8-二氟-2,2-二甲基-3,4-二氢-2H-铬-4-基)-N'-1H-吲唑-4-基脲; N-(7-(3,3-二甲基丁基)-3,4-二氢-2H-铬-4-基)-N'-1H-吲唑-4-基脲; N-(7-叔丁基-2,2-二甲基-3,4-二氢-2H-铬-4-基)-N'-1H-吲唑-4-基脲; N-(2,2-二乙基-7-氟-3,4-二氢-2H-铬-4-基)-N'-(1-甲基-1H-吲唑-4-基)脲; N-(7,8-二氟-3,4-二氢-2H-铬-4-基)-N'-1H-吲唑-4-基脲; N-(7-氟-2,2-二丙基-3,4-二氢-2H-铬-4-基)-N'-1H-吲唑-4-基脲; N-(2,2-二丁基-7-氟-3,4-二氢-2H-铬-4-基)-N'-1H-吲唑-4-基脲; N-(2-叔丁基-7-氟-3,4-二氢-2H-铬-4-基)-N'-1H-吲唑-4-基脲; 7,6-1-1-1-1 -1-1-1-1-1-1-1-1-1-1-1-3,4-二氢-2h-铬-4-il尿素; N-[(4R)-3,4-二氢-2h-铬-4-il]-n'(7-羟基-5,6,7,(7-1-1-1-1-1-1- 1-1-1-1-1-1-1-1-1-4-il)尿素; 1-(7-氟螺[croman-2,1'-ciciochotan]-4-il)-3-(1h -indazol-4-il)尿素;(1-(1)-1-1-(1-(1--)(1 1.尿素[cr-2,1L环己基]-4-il)-3-(1h -indazol-4-il)尿素; 1-(7-叔丁基吡咯烷酮[cr-2],-1-1-1-1-1-1-1-1-1-1-1-1-1-1- 1-1-1-1'-环戊酮]-4-1)尿素; 1-(7-etoxiespiro [croman-2,1'-环戊酮]-4-il)-3-(1h-吲唑-4-il )尿素; 1]]-1]-1-,1-(1-,1-(1-[[L)3-(7-甲氧基螺[cr-2,1'-环己烷]-4-il))尿素;(+-)1-(3,4-二氢-2),-甲苯甲苯甲苯甲苯3-(苯甲苯甲苯甲苯甲苯甲苯-(6)-1-(6-甲氧基-3,4-二氢-2 ,2-二甲基-2h-1-苯并重氮-4-il)-3-(异奎宁-5-il)尿激酶; 3,3,3,3,3-甲基甲基甲基甲苯-甲苯,3,3-甲基甲苯-an-4 -il)-3-(1-甲基异奎宁-5-il)尿素;(+-)1-(6-溴-3,4-二氢-2)尿素;(+-)1-(3,4-二氢-螺旋-[2h-1-be nzodiazepine-2,1'-cyclobutan]-4-il)-3-(isoquinolin-5-il)尿素;(+)1-(3,4-dihydro-spiro-- [2H-1-benzopyran-2,1 '-环丁烷] -4-基)-3-(异喹啉-5-基)脲; (-)1-(3,4-二氢-螺-[2H-1-苯并吡喃-2,1'-环丁烷] -4-基)-3-(异喹啉-5-基)脲; (+-)1-(3,4-二氢-螺-[2H-1-苯并吡喃-2,1'-环丁烷] -4-基)-3-(8-氯异喹啉-5-基)脲; (+-)1-(3,4-二氢-螺-[2H-1-苯并吡喃-2,1'-环丁烷] -4-基)-3-(3-甲基异喹啉-5-基)脲; (+-)1-(3,4-二氢-螺-[2H-1-苯并吡喃-2,1'-环丁烷] -4-基)-3-(1-甲基异喹啉-5-基)脲; (+-)1-(3,4-二氢-6-甲基-螺-[2H-1-苯并吡喃-2,1'-环丁烷] -4-基)-3-(异喹啉-5-基)脲; (+-)1-(3,4-二氢-7-甲基-螺-[2H-1-苯并吡喃-2,1'-环丁烷] -4-基)-3-(异喹啉-5-基)脲; ]] ,, [1-[1-[3-[3-[3-[3-[3-[3-[3-[3-2h-1-苯并吡喃-2,1'-环丁烷]-4-il] -3-(异喹啉-5-il)尿素; (+-)1-(3),(1)1 --------(1 -------- 1.1-2,1'-环丁烷]-4-il)-3-(异喹啉5-il)尿素; 1--(与-1-不同)(1--)(1--)(与-2 h-1-苯并吡喃2,1'-环丁烷不同)-4-il)-3 -(3-甲基异奎宁-5-il)尿素; 1-(1-)(1-)(1-)(1-)(1-)(1-)(1-1。二氢螺旋-[2h-1-苯并重氮2,1'-环己烷]-4 -il)-3-(异喹啉-5-il)尿素;(1--(2h-1-苯并吡喃-2,1'-环丁烷]-4-il)-3-(异喹啉-5-il)尿素;( +-)1-(6-bromo-3),6]-[6]-[6]-[6]-1-[6]-1-4-[6-[6]-4-4-4 -1。Zopiran-2,1'-环丁烷]-4-il)-3-(异喹啉-5-il)尿素;-)(不同于-1-)(1--(1--)(1--) (与5不同)1-(氯-1--)(3-[2h-1-苯并吡喃-2,1'-环丁烷]-4-il)-3-(8-氯异喹啉-5-il)尿素(+-)1-(6-氟-3)

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号